Surrogate Immunohistochemical Markers of Proliferation and Embryonic Stem Cells in Distinguishing Ameloblastoma from Ameloblastic Carcinoma
Open Access
- 4 October 2024
- journal article
- research article
- Published by Springer Nature in Head and Neck Pathology
- Vol. 18 (1) , 1-12
Abstract
Purpose: The current study aimed to investigate the use of surrogate immunohistochemical (IHC) markers of proliferation and stem cells to distinguish ameloblastoma (AB) from ameloblastic carcinoma (AC). Methods: The study assessed a total of 29 ACs, 6 ABs that transformed into ACs, and a control cohort of 20 ABs. The demographics and clinicopathologic details of the included cases of AC were recorded. The Ki-67 proliferation index was scored through automated methods with the QuPath open-source software platform. For SOX2, OCT4 and Glypican-3 IHC, each case was scored using a proportion of positivity score combined with an intensity score to produce a total score. Results: All cases of AC showed a relatively high median proliferation index of 41.7%, with statistically significant higher scores compared to ABs. ABs that transformed into ACs had similar median proliferation scores to the control cohort of ABs. Most cases of AC showed some degree of SOX2 expression, with 58.6% showing high expression. OCT4 expression was not seen in any case of AC. GPC-3 expression in ACs was limited, with high expression in 17.2% of ACs. Primary ACs showed higher median proliferation scores and degrees of SOX2 and GPC-3 expression than secondary cases. Regarding SOX2, OCT4 and GPC-3 IHC expression, no statistically significant differences existed between the cohort of ABs and ACs. Conclusion: Ki-67 IHC as a proliferation marker, particularly when assessed via automated methods, was helpful in distinguishing AC from AB cases. In contrast to other studies, surrogate IHC markers of embryonic stem cells, SOX2, OCT4 and GPC-3, were unreliable in distinguishing the two entities.Keywords
Funding Information
- Research Development Programme (RDP) grant, University of Pretoria (RDP)
- University of Pretoria
This publication has 59 references indexed in Scilit:
- Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Odontogenic and Maxillofacial Bone TumoursHead and Neck Pathology, 2022
- Oct-4 and CD44 in epithelial stem cells like of benign odontogenic lesionsHistochemistry and Cell Biology, 2018
- Malignant Odontogenic Tumors: An Update on Selected TumorsHead and Neck Pathology, 2014
- Evaluation of SOX2 as a potential marker for ameloblastic carcinomaOral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 2014
- The role of glypicans in Hedgehog signalingMatrix Biology, 2014
- Inactivation of Wnt signaling by a human antibody that recognizes the heparan sulfate chains of glypican-3 for liver cancer therapyHepatology, 2014
- Glypican‐3 antibodies: A new therapeutic target for liver cancerFEBS Letters, 2013
- Glypican-3 Inhibits Hedgehog Signaling during Development by Competing with Patched for Hedgehog BindingDevelopmental Cell, 2008
- Ameloblastic Carcinoma: Report of a New Case, Literature Review, and Comparison to AmeloblastomaJournal of Oral and Maxillofacial Surgery, 2007
- The Ki-67 protein: From the known and the unknownJournal of Cellular Physiology, 2000